XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statement Of Cash Flows
 3 Months Ended
Mar. 31, 2022
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (1,025,824)
Adjustments to reconcile net income to net cash used in operating activities:  
Interest earned on marketable securities held in Trust Account (121,891)
Unrealized loss on marketable securities held in Trust Account 291,686
Compensation expense due to advisor 362,500
Changes in operating assets and liabilities:  
Prepaid expenses (735,039)
Accrued expenses 301,244
Net cash used in operating activities (927,324)
Cash Flows from Investing Activities:  
Investment of cash into Trust Account (306,000,000)
Net cash used in investing activities (306,000,000)
Cash Flows from Financing Activities  
Proceeds from sale of Units, net of underwriting discounts paid 294,240,000
Proceeds from sale of Private Placement Warrants 13,850,000
Proceeds from promissory note – related party 49,262
Repayment of promissory note – related party (149,539)
Payment of offering costs (731,830)
Net cash provided by financing activities 307,257,893
Net Change in Cash 330,569
Cash – Beginning of period 0
Cash – End of period 330,569
Non-Cash investing and financing activities:  
Offering costs included in accrued offering costs 717,219
Initial classification of Series A common stock subject to possible redemption 306,000,000
Deferred underwriting fee payable $ 10,500,000